Mutation spectra of the BRCA1/2 genes in human breast and ovarian cancer and germline

Yumiko Koi,Arisa Watanabe,Akari Kawasaki,Satomi Ideo,Nao Matsutani,Kaname Miyashita,Seijiro Shioi,Eriko Tokunaga,Mototsugu Shimokawa,Yoshimichi Nakatsu,Isao Kuraoka,Shinya Oda

DOI: https://doi.org/10.1002/em.22614

2024-06-13

Environmental and Molecular Mutagenesis

Abstract:Annotating genomic sequence alterations is sometimes a difficult decision, particularly in missense variants with uncertain pathogenic significance and also in those presumed as germline pathogenic variants. We here suggest that mutation spectrum may also be useful for judging them. From the public databases, 982 BRCA1/1861 BRCA2 germline missense variants and 294 BRCA1/420 BRCA2 somatic missense variants were obtained. We then compared their mutation spectra, i.e., the frequencies of two transition‐ and four transversion‐type mutations, in each category. Intriguingly, in BRCA1 variants, A:T to C:G transversion, which was relatively frequent in the germline, was extremely rare in somatic, particularly breast cancer, cells (p = .03). Conversely, A:T to T:A transversion was most infrequent in the germline, but not rare in somatic cells. Thus, BRCA1 variants with A:T to T:A transversion may be suspected as somatic, and those with A:T to C:G as being in the germline. These tendencies of mutation spectrum may also suggest the biological and chemical origins of the base alterations. On the other hand, unfortunately, variants of uncertain significance (VUS) were not distinguishable by mutation spectrum. Our findings warrant further and more detailed studies.

toxicology,environmental sciences,genetics & heredity